Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$915M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$576M |
| 3 |
NVIDIA
NVDA
|
+$355M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$321M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$991M |
| 2 |
Cigna
CI
|
+$435M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$432M |
| 4 |
Medtronic
MDT
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 10.89% |
| 3 | Healthcare | 10.04% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MHN
3701
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $144K | ﹤0.01% |
13,685
| – | – |
|
3702
Ginkgo Bioworks
DNA
$612M
| $144K | ﹤0.01% |
2,124
-8
| -0.4% | -$490 |
|
3703
ZipRecruiter
ZIP
$346M
| $143K | ﹤0.01% |
+10,270
| New | +$127K |
|
|
TRUE
3704
DELISTED
TrueCar
TRUE
| $142K | ﹤0.01% |
41,126
-10,143
| -20% | -$25.7K |
|
|
DMO
3705
Western Asset Mortgage Opportunity Fund
DMO
$119M
| $141K | ﹤0.01% |
12,616
| – | – |
|
3706
Design Therapeutics
DSGN
$849M
| $140K | ﹤0.01% |
+53,015
| New | +$121K |
|
3707
Sasol
SSL
$7.01B
| $140K | ﹤0.01% |
14,068
-10,491
| -43% | -$123K |
|
|
FAX
3708
abrdn Asia-Pacific Income Fund
FAX
$594M
| $139K | ﹤0.01% |
8,531
-1,415
| -14% | -$22K |
|
|
VLRS
3709
Controladora Vuela Compania de Aviacion
VLRS
$962M
| $139K | ﹤0.01% |
+14,781
| New | +$108K |
|
3710
Nano X Imaging
NNOX
$69.6M
| $139K | ﹤0.01% |
21,750
-18,128
| -45% | -$113K |
|
3711
QuantumScape Corp
QS
$3.4B
| $135K | ﹤0.01% |
19,474
+2,713
| +16% | +$17.1K |
|
|
EGRX
3712
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $135K | ﹤0.01% |
25,869
-231,611
| -90% | -$2.29M |
|
3713
Ecopetrol
EC
$33.7B
| $135K | ﹤0.01% |
11,284
+718
| +7% | +$8.71K |
|
3714
Garrett Motion
GTX
$5.86B
| $133K | ﹤0.01% |
13,723
-88
| -0.6% | -$679 |
|
3715
Oportun Financial
OPRT
$278M
| $133K | ﹤0.01% |
+33,896
| New | +$145K |
|
3716
Wave Life Sciences
WVE
$1.17B
| $131K | ﹤0.01% |
+25,999
| New | +$139K |
|
|
OKLO
3717
Oklo
OKLO
$7.48B
| $130K | ﹤0.01% |
+12,282
| New | +$127K |
|
3718
Ocular Therapeutix
OCUL
$1.87B
| $129K | ﹤0.01% |
29,000
-3,610
| -11% | -$10.7K |
|
|
PSTX
3719
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $126K | ﹤0.01% |
+37,514
| New | +$96.6K |
|
3720
Archer Aviation
ACHR
$3.97B
| $126K | ﹤0.01% |
20,459
+7,836
| +62% | +$44.5K |
|
3721
ADT
ADT
$5.63B
| $125K | ﹤0.01% |
18,328
-186
| -1% | -$1.16K |
|
3722
Suzano
SUZ
$10.3B
| $124K | ﹤0.01% |
+10,704
| New | +$116K |
|
3723
Mistras Group
MG
$503M
| $122K | ﹤0.01% |
16,675
+5,175
| +45% | +$31.8K |
|
|
TEAD
3724
Teads Holding Co
TEAD
$80.2M
| $122K | ﹤0.01% |
27,828
+8,694
| +45% | +$36.8K |
|
3725
Star Group
SGU
$422M
| $121K | ﹤0.01% |
10,500
| – | – |
|
Similar funds
Ameriprise's Q4 2023 Portfolio in Review
As of Q4 2023, Ameriprise held 4,040 positions worth $334B, up 9.7% from $305B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q4 2023 filing shows 156 new, 1,686 increased, 1,943 reduced and 146 closed positions. Its largest new stake was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M. The largest sale was Broadcom, an estimated $991M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2023 buy was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M.
- Ameriprise added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $915M increase.
- Ameriprise's biggest Q4 2023 reduction was Broadcom, cutting an estimated $991M.
- Ameriprise fully exited Activision Blizzard in Q4 2023, selling an estimated $374M.
- Ameriprise's ten largest holdings make up 17% of its $334B portfolio in Q4 2023.
- Ameriprise opened 156 new positions and closed 146 in Q4 2023.
- Ameriprise's portfolio value rose 9.7% quarter-over-quarter to $334B.
Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.